Insider Cluster Builds: Recent social media activity centers on a wave of director purchases at GE HealthCare, with one executive adding over $640,000 in shares last week and bringing the total cluster to more than $6 million in the past month.
Stock Pressure Lingers: Participants note the buys follow a sharp selloff that has left shares near multi-month lows and down over 20 percent year-to-date, after first-quarter results highlighted tariff and inflation headwinds.
Analyst Lens Shifts: Commentary also references a recent upgrade to neutral by a major bank, which cited the pullback as better aligning valuation with ongoing execution and China-related risks.
Note: This discussion summary was generated from an AI condensation of post data.
GE HealthCare Insider Trading Activity
GE HealthCare insiders have traded $GEHC stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by insiders over the last 6 months:
- H LAWRENCE JR CULP purchased 80,805 shares for an estimated $5,000,076
- KEVIN LOBO purchased 10,000 shares for an estimated $641,800
- PETER J ARDUINI (President and CEO) purchased 4,169 shares for an estimated $249,827
- JAMES SACCARO (Chief Financial Officer) purchased 3,310 shares for an estimated $200,585
- FRANK R JIMENEZ (GC & Corporate Secretary) purchased 1,750 shares for an estimated $105,787
- RODNEY F HOCHMAN purchased 1,618 shares for an estimated $100,364
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
GE HealthCare Revenue
GE HealthCare had revenues of $5.1B in Q1 2026. This is an increase of 7.41% from the same period in the prior year.
You can track GEHC financials on Quiver Quantitative's GEHC stock page.
You can access data on GEHC stock through the Quiver Quantitative API.
GE HealthCare Congressional Stock Trading
Members of Congress have traded $GEHC stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:
- REPRESENTATIVE TERRI A. SEWELL sold up to $15,000 on 03/25.
- REPRESENTATIVE WARREN DAVIDSON sold up to $15,000 on 03/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
GE HealthCare Hedge Fund Activity
We have seen 511 institutional investors add shares of GE HealthCare stock to their portfolio, and 710 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 33,568,289 shares (-98.8%) from their portfolio in Q1 2026, for an estimated $2,335,010,182
- BARROW HANLEY MEWHINNEY & STRAUSS LLC added 5,378,190 shares (+82.7%) to their portfolio in Q1 2026, for an estimated $374,106,896
- CYNOSURE GROUP, LLC removed 4,344,817 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $302,225,470
- CAPITAL RESEARCH GLOBAL INVESTORS removed 4,253,599 shares (-16.8%) from their portfolio in Q1 2026, for an estimated $295,880,346
- HOLOCENE ADVISORS, LP removed 2,246,830 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $156,289,494
- MIZUHO MARKETS AMERICAS LLC removed 1,945,500 shares (-99.3%) from their portfolio in Q1 2026, for an estimated $135,328,980
- MIZUHO MARKETS CAYMAN LP added 1,945,500 shares (+173.2%) to their portfolio in Q1 2026, for an estimated $135,328,980
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
GE HealthCare Analyst Ratings
Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 04/30/2026
- BTIG issued a "Buy" rating on 04/29/2026
- Piper Sandler issued a "Overweight" rating on 01/30/2026
To track analyst ratings and price targets for GE HealthCare, check out Quiver Quantitative's $GEHC forecast page.
GE HealthCare Price Targets
Multiple analysts have issued price targets for $GEHC recently. We have seen 14 analysts offer price targets for $GEHC in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Graham Doyle from UBS set a target price of $69.0 on 05/21/2026
- Larry Biegelsen from Wells Fargo set a target price of $75.0 on 04/30/2026
- Matt Miksic from Barclays set a target price of $78.0 on 04/30/2026
- Vijay Kumar from Evercore ISI Group set a target price of $80.0 on 04/30/2026
- David Roman from Goldman Sachs set a target price of $65.0 on 04/30/2026
- Joanne Wuensch from Citigroup set a target price of $65.0 on 04/30/2026
- Robbie Marcus from JP Morgan set a target price of $65.0 on 04/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
